TreeWAS – Variant ID: rs17143387

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
O36.0 Maternal care for rhesus isoimmunisation	0.000	0.944	0.056
O36 Maternal care for other known or suspected foetal problems	0.000	0.946	0.054
O35 Maternal care for known or suspected foetal abnormality and damage	0.000	0.947	0.053
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.000	0.947	0.053
O30-O48 Maternal care related to the fetus and amniotic cavity and possible delivery problems	0.000	0.949	0.051
O48 Prolonged pregnancy	0.000	0.951	0.049
O36.6 Maternal care for excessive foetal growth	0.000	0.953	0.047
O44 Placenta praevia	0.000	0.954	0.046
O46 Antepartum haemorrhage, not elsewhere classified	0.000	0.955	0.045
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.000	0.955	0.045
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.000	0.958	0.042
O42 Premature rupture of membranes	0.000	0.958	0.042
O44.1 Placenta praevia with haemorrhage	0.000	0.959	0.041
O36.3 Maternal care for signs of foetal hypoxia	0.000	0.960	0.040
O41 Other disorders of amniotic fluid and membranes	0.000	0.961	0.039
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.000	0.961	0.039
O36.2 Maternal care for hydrops foetalis	0.000	0.961	0.039
O36.1 Maternal care for other isoimmunisation	0.000	0.961	0.039
O36.4 Maternal care for intra-uterine death	0.000	0.961	0.039
O42.9 Premature rupture of membranes, unspecified	0.000	0.961	0.039
O45 Premature separation of placenta [abruptio placentae]	0.000	0.961	0.038
O35.7 Maternal care for (suspected) damage to foetus by other medical procedures	0.000	0.962	0.038
O35.6 Maternal care for (suspected) damage to foetus by radiation	0.000	0.962	0.038
O35.5 Maternal care for (suspected) damage to foetus by drugs	0.000	0.962	0.038
O35.4 Maternal care for (suspected) damage to foetus from alcohol	0.000	0.962	0.038
O35.3 Maternal care for (suspected) damage to foetus from viral disease in mother	0.000	0.962	0.038
O35.2 Maternal care for (suspected) hereditary disease in foetus	0.000	0.962	0.038
O35.0 Maternal care for (suspected) central nervous system malformation in foetus	0.000	0.962	0.038
O44.0 Placenta praevia specified as without haemorrhage	0.000	0.962	0.038
O36.9 Maternal care for foetal problem, unspecified	0.000	0.962	0.038
O46.9 Antepartum haemorrhage, unspecified	0.000	0.962	0.038
O40 Polyhydramnios	0.000	0.963	0.037
O33 Maternal care for known or suspected disproportion	0.000	0.963	0.037
O31 Complications specific to multiple gestation	0.000	0.963	0.037
O36.5 Maternal care for poor foetal growth	0.000	0.963	0.037
O46.8 Other antepartum haemorrhage	0.000	0.963	0.037
O36.8 Maternal care for other specified foetal problems	0.000	0.963	0.037
O30 Multiple gestation	0.000	0.964	0.036
O41.0 Oligohydramnios	0.000	0.967	0.033
O46.0 Antepartum haemorrhage with coagulation defect	0.000	0.967	0.032
O42.1 Premature rupture of membranes, onset of labour after 24 hours	0.000	0.969	0.031
O42.2 Premature rupture of membranes, labour delayed by therapy	0.000	0.970	0.030
O45.9 Premature separation of placenta, unspecified	0.000	0.971	0.029
O43 Placental disorders	0.000	0.971	0.029
O41.9 Disorder of amniotic fluid and membranes, unspecified	0.000	0.972	0.028
O41.1 Infection of amniotic sac and membranes	0.000	0.972	0.028
O45.8 Other premature separation of placenta	0.000	0.972	0.028
O45.0 Premature separation of placenta with coagulation defect	0.000	0.972	0.028
O31.8 Other complications specific to multiple gestation	0.000	0.973	0.027
O31.2 Continuing pregnancy after intra-uterine death of one foetus or more	0.000	0.973	0.027
O31.1 Continuing pregnancy after abortion of one foetus or more	0.000	0.973	0.027
O31.0 Papyraceous foetus	0.000	0.973	0.027
O33.9 Maternal care for disproportion, unspecified	0.000	0.973	0.027
O33.8 Maternal care for disproportion of other origin	0.000	0.973	0.027
O33.7 Maternal care for disproportion due to other foetal deformities	0.000	0.973	0.027
O33.6 Maternal care for disproportion due to hydrocephalic foetus	0.000	0.973	0.027
O33.5 Maternal care for disproportion due to unusually large foetus	0.000	0.973	0.027
O33.4 Maternal care for disproportion of mixed maternal and foetal origin	0.000	0.973	0.027
O33.3 Maternal care for disproportion due to outlet contraction of pelvis	0.000	0.973	0.027
O33.2 Maternal care for disproportion due to inlet contraction of pelvis	0.000	0.973	0.027
O33.1 Maternal care for disproportion due to generally contracted pelvis	0.000	0.973	0.027
O33.0 Maternal care for disproportion due to deformity of maternal pelvic bones	0.000	0.973	0.027
O30.9 Multiple gestation, unspecified	0.000	0.974	0.026
O30.8 Other multiple gestation	0.000	0.974	0.026
O30.2 Quadruplet pregnancy	0.000	0.974	0.026
O30.1 Triplet pregnancy	0.000	0.974	0.026
O41.8 Other specified disorders of amniotic fluid and membranes	0.000	0.975	0.025
O30.0 Twin pregnancy	0.000	0.975	0.024
Z36.9 Antenatal screening, unspecified	0.000	0.976	0.024
O43.9 Placental disorder, unspecified	0.000	0.979	0.021
O43.2 Morbidly adherent placenta	0.000	0.979	0.021
O43.0 Placental transfusion syndromes	0.000	0.979	0.021
O43.8 Other placental disorders	0.000	0.982	0.018
O43.1 Malformation of placenta	0.000	0.983	0.016
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.000	0.984	0.016
B34.9 Viral infection, unspecified	0.015	0.985	0.000
O47 False labour	0.000	0.985	0.015
Z96.0 Presence of urogenital implants	0.014	0.986	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.000	0.988	0.012
B37.8 Candidiasis of other sites	0.000	0.988	0.012
O47.0 False labour before 37 completed weeks of gestation	0.000	0.988	0.012
O34.4 Maternal care for other abnormalities of cervix	0.000	0.990	0.009
K63.8 Other specified diseases of intestine	0.010	0.990	0.000
O32 Maternal care for known or suspected malpresentation of foetus	0.000	0.990	0.009
K11.5 Sialolithiasis	0.009	0.991	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.000	0.991	0.009
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.000	0.991	0.009
O34.6 Maternal care for abnormality of vagina	0.000	0.991	0.009
O34.5 Maternal care for other abnormalities of gravid uterus	0.000	0.991	0.009
O34.0 Maternal care for congenital malformation of uterus	0.000	0.991	0.009
B34 Viral infection of unspecified site	0.008	0.992	0.000
O34.3 Maternal care for cervical incompetence	0.000	0.992	0.007
O34.7 Maternal care for abnormality of vulva and perineum	0.000	0.992	0.007
O32.9 Maternal care for malpresentation of foetus, unspecified	0.000	0.993	0.007
O32.6 Maternal care for compound presentation	0.000	0.993	0.007
O32.4 Maternal care for high head at term	0.000	0.993	0.007
B34.4 Papovirus infection, unspecified	0.006	0.993	0.000
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more	0.000	0.993	0.006
B34.3 Parvovirus infection, unspecified	0.006	0.994	0.000
B34.2 Coronavirus infection, unspecified	0.006	0.994	0.000
B34.1 Enterovirus infection, unspecified	0.006	0.994	0.000
B34.0 Adenovirus infection, unspecified	0.006	0.994	0.000
O34.1 Maternal care for tumour of corpus uteri	0.000	0.994	0.006
K11 Diseases of salivary glands	0.006	0.994	0.000
O32.3 Maternal care for face, brow and chin presentation	0.000	0.994	0.006
B34.8 Other viral infections of unspecified site	0.006	0.994	0.000
K11.9 Disease of salivary gland, unspecified	0.006	0.994	0.000
O32.8 Maternal care for other malpresentation of foetus	0.000	0.994	0.006
K11.2 Sialoadenitis	0.006	0.994	0.000
O32.0 Maternal care for unstable lie	0.000	0.994	0.005
K11.3 Abscess of salivary gland	0.006	0.994	0.000
O32.1 Maternal care for breech presentation	0.000	0.994	0.006
Z36 Antenatal screening	0.000	0.995	0.005
T78.3 Angioneurotic oedema	0.005	0.995	0.000
T78 Adverse effects, not elsewhere classified	0.005	0.995	0.000
I21.4 Acute subendocardial myocardial infarction	0.000	0.995	0.005
T78.0 Anaphylactic shock due to adverse food reaction	0.005	0.995	0.000
K11.4 Fistula of salivary gland	0.005	0.995	0.000
K11.0 Atrophy of salivary gland	0.005	0.995	0.000
K11.8 Other diseases of salivary glands	0.005	0.995	0.000
T78.2 Anaphylactic shock, unspecified	0.005	0.995	0.000
O47.9 False labour, unspecified	0.001	0.995	0.004
T78.4 Allergy, unspecified	0.005	0.995	0.000
Z36.8 Other antenatal screening	0.000	0.995	0.005
T78.1 Other adverse food reactions, not elsewhere classified	0.004	0.995	0.000
K11.1 Hypertrophy of salivary gland	0.004	0.996	0.000
O32.2 Maternal care for transverse and oblique lie	0.001	0.996	0.004
Z87.8 Personal history of other specified conditions	0.004	0.996	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.996	0.004
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.996	0.004
Y04.8 Other specified place	0.004	0.996	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.996	0.004
T78.9 Adverse effect, unspecified	0.004	0.996	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.996	0.004
T78.8 Other adverse effects, not elsewhere classified	0.004	0.996	0.000
K11.7 Disturbances of salivary secretion	0.004	0.996	0.000
K11.6 Mucocele of salivary gland	0.004	0.996	0.000
R01.1 Cardiac murmur, unspecified	0.000	0.996	0.004
I67.9 Cerebrovascular disease, unspecified	0.000	0.996	0.004
E11.3 With ophthalmic complications	0.003	0.997	0.000
Z48.0 Attention to surgical dressings and sutures	0.003	0.997	0.000
M54.16 Radiculopathy (Lumbar region)	0.000	0.997	0.003
B25-B34 Other viral diseases	0.003	0.997	0.000
N85.4 Malposition of uterus	0.000	0.997	0.003
T66-T78 Other and unspecified effects of external causes	0.003	0.997	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.000	0.997	0.003
Y04 Assault by bodily force	0.003	0.997	0.000
T66 Unspecified effects of radiation	0.003	0.997	0.000
S72.10 Pertrochanteric fracture (closed)	0.000	0.997	0.003
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.997	0.002
M47.12 Other spondylosis with myelopathy (Cervical region)	0.000	0.997	0.003
F32.2 Severe depressive episode without psychotic symptoms	0.000	0.997	0.003
M41.96 Scoliosis, unspecified (Lumbar region)	0.000	0.997	0.003
T68 Hypothermia	0.003	0.997	0.000
C50.3 Lower-inner quadrant of breast	0.000	0.997	0.003
O47.1 False labour at or after 37 completed weeks of gestation	0.000	0.997	0.002
H05.0 Acute inflammation of orbit	0.000	0.997	0.003
B33 Other viral diseases, not elsewhere classified	0.002	0.997	0.000
B30 Viral conjunctivitis	0.002	0.997	0.000
B26 Mumps	0.002	0.997	0.000
T75 Effects of other external causes	0.003	0.997	0.000
N81.3 Complete uterovaginal prolapse	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.003	0.997	0.000
T74 Maltreatment syndromes	0.002	0.997	0.000
T73 Effects of other deprivation	0.002	0.997	0.000
T69 Other effects of reduced temperature	0.002	0.997	0.000
T67 Effects of heat and light	0.002	0.997	0.000
H05.8 Other disorders of orbit	0.000	0.997	0.003
Y04.5 Trade and service area	0.002	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.997	0.003
H05.2 Exophthalmic conditions	0.000	0.997	0.003
T71 Asphyxiation	0.002	0.997	0.000
B25 Cytomegaloviral disease	0.002	0.997	0.000
S19.9 Unspecified injury of neck	0.000	0.997	0.002
Y04.9 Unspecified place	0.002	0.997	0.000
Y04.4 Street and highway	0.002	0.997	0.000
Y04.0 Home	0.002	0.997	0.000
Y04.7 Farm	0.002	0.997	0.000
Y04.6 Industrial and construction area	0.002	0.997	0.000
Y04.3 Sports and athletics area	0.002	0.997	0.000
Y04.2 School, other institution and public administrative area	0.002	0.997	0.000
Y04.1 Residential institution	0.002	0.997	0.000
B27 Infectious mononucleosis	0.002	0.997	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.998	0.002
T70 Effects of air pressure and water pressure	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
H05 Disorders of orbit	0.000	0.998	0.002
F32.3 Severe depressive episode with psychotic symptoms	0.000	0.998	0.002
T75.4 Effects of electric current	0.002	0.998	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
B25.8 Other cytomegaloviral diseases	0.002	0.998	0.000
F32.1 Moderate depressive episode	0.000	0.998	0.002
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
B26.9 Mumps without complication	0.002	0.998	0.000
B26.8 Mumps with other complications	0.002	0.998	0.000
B26.3 Mumps pancreatitis	0.002	0.998	0.000
B26.2 Mumps encephalitis	0.002	0.998	0.000
B26.1 Mumps meningitis	0.002	0.998	0.000
B26.0 Mumps orchitis	0.002	0.998	0.000
B30.9 Viral conjunctivitis, unspecified	0.002	0.998	0.000
B30.8 Other viral conjunctivitis	0.002	0.998	0.000
B30.3 Acute epidemic haemorrhagic conjunctivitis (enteroviral)	0.002	0.998	0.000
B30.2 Viral pharyngoconjunctivitis	0.002	0.998	0.000
B30.1 Conjunctivitis due to adenovirus	0.002	0.998	0.000
B30.0 Keratoconjunctivitis due to adenovirus	0.002	0.998	0.000
B33.8 Other specified viral diseases	0.002	0.998	0.000
B33.4 Hantavirus (cardio-)pulmonary syndrome [HPS] [HCPS]	0.002	0.998	0.000
B33.3 Retrovirus infections, not elsewhere classified	0.002	0.998	0.000
B33.2 Viral carditis	0.002	0.998	0.000
B33.1 Ross River disease	0.002	0.998	0.000
B33.0 Epidemic myalgia	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
T75.8 Other specified effects of external causes	0.002	0.998	0.000
T75.3 Motion sickness	0.002	0.998	0.000
T75.2 Effects of vibration	0.002	0.998	0.000
T75.1 Drowning and nonfatal submersion	0.002	0.998	0.000
T75.0 Effects of lightning	0.002	0.998	0.000
H36.0 Diabetic retinopathy	0.002	0.998	0.000
T67.9 Effects of heat and light, unspecified	0.002	0.998	0.000
T67.8 Other effects of heat and light	0.002	0.998	0.000
T67.7 Heat oedema	0.002	0.998	0.000
T67.6 Heat fatigue, transient	0.002	0.998	0.000
T67.5 Heat exhaustion, unspecified	0.002	0.998	0.000
T67.4 Heat exhaustion due to salt depletion	0.002	0.998	0.000
T67.3 Heat exhaustion, anhydrotic	0.002	0.998	0.000
T67.2 Heat cramp	0.002	0.998	0.000
T67.1 Heat syncope	0.002	0.998	0.000
T67.0 Heatstroke and sunstroke	0.002	0.998	0.000
T69.9 Effect of reduced temperature, unspecified	0.002	0.998	0.000
T69.8 Other specified effects of reduced temperature	0.002	0.998	0.000
T69.1 Chilblains	0.002	0.998	0.000
T69.0 Immersion hand and foot	0.002	0.998	0.000
T73.9 Effect of deprivation, unspecified	0.002	0.998	0.000
T73.8 Other effects of deprivation	0.002	0.998	0.000
T73.3 Exhaustion due to excessive exertion	0.002	0.998	0.000
T73.2 Exhaustion due to exposure	0.002	0.998	0.000
T73.1 Effects of thirst	0.002	0.998	0.000
T73.0 Effects of hunger	0.002	0.998	0.000
T74.9 Maltreatment syndrome, unspecified	0.002	0.998	0.000
T74.8 Other maltreatment syndromes	0.002	0.998	0.000
T74.3 Psychological abuse	0.002	0.998	0.000
T74.2 Sexual abuse	0.002	0.998	0.000
T74.1 Physical abuse	0.002	0.998	0.000
T74.0 Neglect or abandonment	0.002	0.998	0.000
Z71.9 Counselling, unspecified	0.002	0.998	0.000
Y00-Y09 Assault	0.002	0.998	0.000
B25.2 Cytomegaloviral pancreatitis	0.002	0.998	0.000
B25.1 Cytomegaloviral hepatitis	0.002	0.998	0.000
B25.0 Cytomegaloviral pneumonitis	0.002	0.998	0.000
S72.1 Pertrochanteric fracture	0.000	0.998	0.002
Y04.09 Assault by bodily force; Home; During unspecified activity	0.002	0.998	0.000
Y04.49 Assault by bodily force; Street and highway; During unspecified activity	0.002	0.998	0.000
Y04.48 Assault by bodily force; Street and highway; While engaged in other specified activities	0.002	0.998	0.000
Y04.99 Assault by bodily force, Unspecified place, During unspecified	0.002	0.998	0.000
B27.8 Other infectious mononucleosis	0.002	0.998	0.000
B27.1 Cytomegaloviral mononucleosis	0.002	0.998	0.000
B27.0 Gammaherpesviral mononucleosis	0.002	0.998	0.000
R01 Cardiac murmurs and other cardiac sounds	0.000	0.998	0.002
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
R01.0 Benign and innocent cardiac murmurs	0.000	0.998	0.002
L71.9 Rosacea, unspecified	0.002	0.998	0.000
T70.9 Effect of air pressure and water pressure, unspecified	0.002	0.998	0.000
T70.8 Other effects of air pressure and water pressure	0.002	0.998	0.000
T70.4 Effects of high-pressure fluids	0.002	0.998	0.000
T70.2 Other and unspecified effects of high altitude	0.002	0.998	0.000
T70.1 Sinus barotrauma	0.002	0.998	0.000
T70.0 Otitic barotrauma	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
H05.9 Disorder of orbit, unspecified	0.000	0.998	0.002
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.000	0.998	0.002
H05.3 Deformity of orbit	0.000	0.998	0.002
H05.1 Chronic inflammatory disorders of orbit	0.000	0.998	0.002
B27.9 Infectious mononucleosis, unspecified	0.002	0.998	0.000
H50.1 Divergent concomitant strabismus	0.002	0.998	0.000
I30.9 Acute pericarditis, unspecified	0.000	0.998	0.002
F32 Depressive episode	0.000	0.998	0.002
Y00 Assault by blunt object	0.002	0.998	0.000
H40.9 Glaucoma, unspecified	0.000	0.998	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
J33.8 Other polyp of sinus	0.000	0.998	0.002
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
C71.2 Temporal lobe	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y09 Assault by unspecified means	0.002	0.998	0.000
Y08 Assault by other specified means	0.002	0.998	0.000
Y07 Other maltreatment syndromes	0.002	0.998	0.000
Y06 Neglect and abandonment	0.002	0.998	0.000
Y05 Sexual assault by bodily force	0.002	0.998	0.000
Y03 Assault by crashing of motor vehicle	0.002	0.998	0.000
Y02 Assault by pushing or placing victim before moving object	0.002	0.998	0.000
Y01 Assault by pushing from high place	0.002	0.998	0.000
S02.80 Fractures of other skull and facial bones (closed)	0.000	0.998	0.002
S72.11 Pertrochanteric fracture (open)	0.000	0.998	0.002
B25.9 Cytomegaloviral disease, unspecified	0.002	0.998	0.000
H05.4 Enophthalmos	0.000	0.998	0.002
R01.2 Other cardiac sounds	0.000	0.998	0.002
T70.3 Caisson disease [decompression sickness]	0.001	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y00.9 Unspecified place	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
D37.5 Rectum	0.000	0.998	0.002
W78.9 Unspecified place	0.002	0.998	0.000
Z71.8 Other specified counselling	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.000	0.998	0.002
W78 Inhalation of gastric contents	0.002	0.998	0.000
X50.4 Street and highway	0.002	0.998	0.000
C06.0 Cheek mucosa	0.002	0.998	0.000
Y00.8 Other specified place	0.001	0.998	0.000
Y00.4 Street and highway	0.001	0.998	0.000
Y00.2 School, other institution and public administrative area	0.001	0.998	0.000
Y00.7 Farm	0.001	0.998	0.000
Y00.6 Industrial and construction area	0.001	0.998	0.000
Y00.5 Trade and service area	0.001	0.998	0.000
Y00.3 Sports and athletics area	0.001	0.998	0.000
Y00.1 Residential institution	0.001	0.998	0.000
I74.5 Embolism and thrombosis of iliac artery	0.002	0.998	0.000
D75.9 Disease of blood and blood-forming organs, unspecified	0.000	0.998	0.002
E83.5 Disorders of calcium metabolism	0.002	0.998	0.000
U89.8 Agent resistant to other single specified antibiotic	0.002	0.998	0.000
W80.9 Unspecified place	0.001	0.998	0.000
X23.9 Unspecified place	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000
Y41.5 Antiviral drugs	0.001	0.998	0.000
Y41.4 Anthelminthics	0.001	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.998	0.000
X59.2 School, other institution and public administrative area	0.001	0.998	0.000
Y54.7 Agents affecting calcification	0.001	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.998	0.000
H40.5 Glaucoma secondary to other eye disorders	0.000	0.998	0.002
Y00.0 Home	0.001	0.998	0.000
Y01.9 Unspecified place	0.001	0.998	0.000
Y01.8 Other specified place	0.001	0.998	0.000
Y01.7 Farm	0.001	0.998	0.000
Y01.6 Industrial and construction area	0.001	0.998	0.000
Y01.5 Trade and service area	0.001	0.998	0.000
Y01.4 Street and highway	0.001	0.998	0.000
Y01.3 Sports and athletics area	0.001	0.998	0.000
Y01.2 School, other institution and public administrative area	0.001	0.998	0.000
Y01.1 Residential institution	0.001	0.998	0.000
Y01.0 Home	0.001	0.998	0.000
Y02.9 Unspecified place	0.001	0.998	0.000
Y02.8 Other specified place	0.001	0.998	0.000
Y02.7 Farm	0.001	0.998	0.000
Y02.6 Industrial and construction area	0.001	0.998	0.000
Y02.5 Trade and service area	0.001	0.998	0.000
Y02.4 Street and highway	0.001	0.998	0.000
Y02.3 Sports and athletics area	0.001	0.998	0.000
Y02.2 School, other institution and public administrative area	0.001	0.998	0.000
Y02.1 Residential institution	0.001	0.998	0.000
Y02.0 Home	0.001	0.998	0.000
Y03.8 Other specified place	0.001	0.998	0.000
Y03.9 Unspecified place	0.001	0.998	0.000
Y03.7 Farm	0.001	0.998	0.000
Y03.6 Industrial and construction area	0.001	0.998	0.000
Y03.5 Trade and service area	0.001	0.998	0.000
Y03.4 Street and highway	0.001	0.998	0.000
Y03.3 Sports and athletics area	0.001	0.998	0.000
Y03.2 School, other institution and public administrative area	0.001	0.998	0.000
Y03.1 Residential institution	0.001	0.998	0.000
Y03.0 Home	0.001	0.998	0.000
Y05.9 Unspecified place	0.001	0.998	0.000
Y05.8 Other specified place	0.001	0.998	0.000
Y05.7 Farm	0.001	0.998	0.000
Y05.6 Industrial and construction area	0.001	0.998	0.000
Y05.5 Trade and service area	0.001	0.998	0.000
Y05.4 Street and highway	0.001	0.998	0.000
Y05.3 Sports and athletics area	0.001	0.998	0.000
Y05.2 School, other institution and public administrative area	0.001	0.998	0.000
Y05.1 Residential institution	0.001	0.998	0.000
Y05.0 Home	0.001	0.998	0.000
Y06.9 By unspecified person	0.001	0.998	0.000
Y06.8 By other specified persons	0.001	0.998	0.000
Y06.2 By acquaintance or friend	0.001	0.998	0.000
Y06.1 By parent	0.001	0.998	0.000
Y06.0 By spouse or partner	0.001	0.998	0.000
Y07.9 By unspecified person	0.001	0.998	0.000
Y07.8 By other specified persons	0.001	0.998	0.000
Y07.3 By official authorities	0.001	0.998	0.000
Y07.2 By acquaintance or friend	0.001	0.998	0.000
Y07.1 By parent	0.001	0.998	0.000
Y07.0 By spouse or partner	0.001	0.998	0.000
Y08.9 Unspecified place	0.001	0.998	0.000
Y08.3 Sports and athletics area	0.001	0.998	0.000
Y08.0 Home	0.001	0.998	0.000
Y08.8 Other specified place	0.001	0.998	0.000
Y08.7 Farm	0.001	0.998	0.000
Y08.6 Industrial and construction area	0.001	0.998	0.000
Y08.5 Trade and service area	0.001	0.998	0.000
Y08.4 Street and highway	0.001	0.998	0.000
Y08.2 School, other institution and public administrative area	0.001	0.998	0.000
Y08.1 Residential institution	0.001	0.998	0.000
Y09.9 Unspecified place	0.001	0.998	0.000
Y09.8 Other specified place	0.001	0.998	0.000
Y09.7 Farm	0.001	0.998	0.000
Y09.6 Industrial and construction area	0.001	0.998	0.000
Y09.5 Trade and service area	0.001	0.998	0.000
Y09.4 Street and highway	0.001	0.998	0.000
Y09.3 Sports and athletics area	0.001	0.998	0.000
Y09.2 School, other institution and public administrative area	0.001	0.998	0.000
Y09.1 Residential institution	0.001	0.998	0.000
Y09.0 Home	0.001	0.998	0.000
W80 Inhalation and ingestion of other objects causing obstruction of respiratory tract	0.001	0.998	0.000
O73.0 Retained placenta, without haemorrhage	0.000	0.998	0.002
W75-W84 Other accidental threats to breathing	0.001	0.998	0.000
A04.5 Campylobacter enteritis	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.001	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.998	0.000
Y54.0 Mineralocorticoids	0.001	0.998	0.000
M41.9 Scoliosis, unspecified	0.000	0.998	0.001
X23 Contact with hornets, wasps and bees	0.001	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
K50.0 Crohn's disease of small intestine	0.001	0.998	0.000
W78.2 School, other institution and public administrative area	0.001	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.998	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.001	0.999	0.000
X00.0 Home	0.001	0.999	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.999	0.000
Y76.2 Prosthetic and other implants, materials and accessory devices	0.001	0.999	0.000
W84 Unspecified threat to breathing	0.001	0.999	0.000
X50 Overexertion and strenuous or repetitive movements	0.001	0.999	0.000
S72.40 Fracture of lower end of femur (closed)	0.000	0.999	0.001
F32.8 Other depressive episodes	0.000	0.999	0.001
Y52.4 Angiotensin-converting-enzyme inhibitors	0.001	0.999	0.000
C06 Malignant neoplasm of other and unspecified parts of mouth	0.001	0.999	0.000
X59 Exposure to unspecified factor	0.001	0.999	0.000
B00.5 Herpesviral ocular disease	0.001	0.999	0.000
W78.8 Other specified place	0.001	0.999	0.000
W78.7 Farm	0.001	0.999	0.000
W78.6 Industrial and construction area	0.001	0.999	0.000
W78.5 Trade and service area	0.001	0.999	0.000
W78.4 Street and highway	0.001	0.999	0.000
W78.3 Sports and athletics area	0.001	0.999	0.000
W78.1 Residential institution	0.001	0.999	0.000
W78.0 Home	0.001	0.999	0.000
W84.9 Unspecified place	0.001	0.999	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.001	0.999	0.000
Y00.21 Assault by blunt object; School, other institution and public administrative area ; While engaged in leisure activity	0.001	0.999	0.000
Y00.42 Assault by blunt object; Street and highway; While working for income	0.001	0.999	0.000
Y00.88 Assault by blunt object : Other specified places :While engaged in other specified activities	0.001	0.999	0.000
C06.2 Retromolar area	0.001	0.999	0.000
G47.8 Other sleep disorders	0.001	0.999	0.000
X23.0 Home	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.001	0.999	0.000
M41.90 Scoliosis, unspecified (Multiple sites in spine)	0.000	0.999	0.001
S72.4 Fracture of lower end of femur	0.000	0.999	0.001
X50.2 School, other institution and public administrative area	0.001	0.999	0.000
S72 Fracture of femur	0.000	0.999	0.001
Y03.89 Assault by crashing of motor vehicle: Other specified places: During unspecified activity	0.001	0.999	0.000
Y08.08 Assault by other specified means; Home; While engaged in other specified activities	0.001	0.999	0.000
Y08.30 Assault by other specified means; Sports and athletics area; While engaged in sports activity	0.001	0.999	0.000
Y08.99 Assault by other specified means: Unspecified place: During unspecified activity	0.001	0.999	0.000
Y08.98 Assault by other specified means; Unspecified place; While engaged in other specified activities	0.001	0.999	0.000
Y09.99 Assault by unspecified means: Unspecified place: During unspecified activity	0.001	0.999	0.000
C03.1 Lower gum	0.001	0.999	0.000
C09.9 Tonsil, unspecified	0.001	0.999	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
Y71.1 Therapeutic (nonsurgical) and rehabilitative devices	0.001	0.999	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.999	0.000
Y76 Obstetric and gynaecological devices associated with adverse incidents	0.001	0.999	0.000
Y71 Cardiovascular devices associated with adverse incidents	0.001	0.999	0.000
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.999	0.001
W80.8 Other specified place	0.001	0.999	0.000
W80.7 Farm	0.001	0.999	0.000
W80.6 Industrial and construction area	0.001	0.999	0.000
W80.5 Trade and service area	0.001	0.999	0.000
W80.4 Street and highway	0.001	0.999	0.000
W80.3 Sports and athletics area	0.001	0.999	0.000
W80.2 School, other institution and public administrative area	0.001	0.999	0.000
W80.1 Residential institution	0.001	0.999	0.000
W80.0 Home	0.001	0.999	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.001	0.999	0.000
W83 Other specified threats to breathing	0.001	0.999	0.000
W81 Confined to or trapped in a low-oxygen environment	0.001	0.999	0.000
W79 Inhalation and ingestion of food causing obstruction of respiratory tract	0.001	0.999	0.000
W77 Threat to breathing due to cave-in, falling earth and other substances	0.001	0.999	0.000
W76 Other accidental hanging and strangulation	0.001	0.999	0.000
W75 Accidental suffocation and strangulation in bed	0.001	0.999	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.000	0.999	0.001
N08.5 Glomerular disorders in systemic connective tissue disorders	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations